Stock comparison

AAPLvsLLY

Apple Inc. vs Eli Lilly and Co. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

AAPL

Apple Inc.

$270.23

-1.16%

Technology$3.97TNASDAQ

LLY

Eli Lilly and Co

$927.03

-6.70%

Pharmaceuticals$884.0BNYSE

60-day price, rebased to 100

AAPL +4.14% · LLY -12.77%

Round-by-round

AAPL 5·LLY 1

EdgeAAPL

Valuation upside

-74.70% vs -92.70% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 11.38 vs 15.74

EdgeAAPL

Fundamental quality

Piotroski 7.00 vs 6.00 (of 9)

EdgeAAPL

Growth + margins

Rule-of-40 20.60 vs -9.10

EdgeAAPL

60-day momentum

+4.14% vs -12.77% price return

EdgeAAPL

Market-cap liquidity

$3.97T vs $884.0B

Verdict

Across 6 categories, AAPL takes the edge with 5 wins to 1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on AAPL or LLY

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.